GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sirio Pharma Co Ltd (SZSE:300791) » Definitions » Accounts Payable & Accrued Expense

Sirio Pharma Co (SZSE:300791) Accounts Payable & Accrued Expense : ¥690 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Sirio Pharma Co Accounts Payable & Accrued Expense?

Sirio Pharma Co's quarterly accounts payable & accrued expense increased from Sep. 2024 (¥593 Mil) to Dec. 2024 (¥661 Mil) and increased from Dec. 2024 (¥661 Mil) to Mar. 2025 (¥690 Mil).

Sirio Pharma Co's annual accounts payable & accrued expense increased from Dec. 2022 (¥434 Mil) to Dec. 2023 (¥628 Mil) and increased from Dec. 2023 (¥628 Mil) to Dec. 2024 (¥661 Mil).

Sirio Pharma Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sirio Pharma Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirio Pharma Co Accounts Payable & Accrued Expense Chart

Sirio Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 302.86 296.45 434.37 628.22 660.81

Sirio Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 467.41 589.37 592.65 660.81 689.69

Sirio Pharma Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sirio Pharma Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sirio Pharma Co Ltd (SZSE:300791) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
SHSE:605339 SHSE:600073 SZSE:000019 SZSE:002570 SHSE:600429 SZSE:002567 SHSE:605300 SZSE:003000 SZSE:002726 SZSE:002481 XSWX:NESN XPAR:BN SHSE:603288 KHC GIS K NSE:NESTLEIND SHSE:600887 TSE:2802 SZSE:300999
Traded in Other Exchanges
N/A
Address
No. 83, Taishan Road, Guangdong Province, Shantou, CHN, 515057
Website
http://www.siriopharm.com
Sirio Pharma Co Ltd is engaged in the research and development, production, sales and technical services of nutrition and health food, food production, sales, import and export of goods.
Executives
Chen Qiong Directors, executives
Yao Zhuang Min Directors, executives
Zheng Li Qun Directors, executives
Yang Rui Directors, executives

Sirio Pharma Co Headlines

No Headlines